Product Description |
The CytoSinct™ TCR αβ Nanobeads, human is used for in vitro enrichment or depletion of TCRα/β+ cells from fresh or frozen peripheral blood mononuclear cells (PBMCs), leukapheresis products or single cell suspension based on the surface expression of human TCRα/β. The surface of Nanobeads are labeled with an anti-human TCRα/β monoclonal antibody. To begin the isolation, Nanobeads are added to the cells. The cells/beads mixed suspension is loaded onto a CytoSinct Column which is placed in the CytoSinct Magnetic Rack, or other compatible columns with magnet. TCRα/β+ cells labeled with CytoSinct Nanobeads are retained within the column and unlabelled cells are flushed out during the wash step. After removal of the magnetic field, TCRα/β+ cells can be easily eluted from the column as the positively selected cell fraction. |
Capacity |
Cat. No.
| Product Name
| Size
| Capacity
|
---|
L00897-1
| CytoSinct™ TCR αβ Nanobeads, human
| 1 mL
| for up to 2.6×109 total cells | L00897-7.5 | CytoSinct™ TCR αβ Nanobeads, human
| 7.5 mL | for up to 2×1010 total cells | |
Reactivity |
Human |
Format |
Bio-degradable matrix coated nanoparticle conjugated to monoclonal mouse anti-human TCRα/β antibodies supplied in phosphate buffered-saline (PBS), containing Human Serum Albumin (HSA). |
Storage |
Store at 2-8 °C. Do not freeze. |
For research use only. Not intended for human and animal therapeutic or diagnostic use.